P-D 182 (Pyridium plus 15 mg / 0.3 mg / 150 mg)
Generic Name: butabarbital/hyoscyamine/phenazopyridine
Pill imprint P-D 182 has been identified as Pyridium plus 15 mg / 0.3 mg / 150 mg.
Pyridium Plus is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. Pyridium Plus 15 mg / 0.3 mg / 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- butabarbital/hyoscyamine/phenazopyridine
- Imprint:
- P-D 182
- Strength:
- 15 mg / 0.3 mg / 150 mg
- Color:
- Purple
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Parke-Davis
More about Pyridium Plus (butabarbital / hyoscyamine / phenazopyridine)
Consumer resources
- Other brands: Urelief Plus, PhenazoForte Plus
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
